Analysts' Opinions Are Mixed on These Healthcare Stocks: Kezar Life Sciences (KZR), Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF) and Cue Health (HLTH)
Cue Health's Hold Rating Amidst Leadership Changes and FDA Setbacks
Cue Health Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Guardant Health (GH), Cue Health (HLTH) and Skye Bioscience (OtherSKYE)
Cue Health's Growth Prospects Amidst Regulatory Challenges: A Buy Rating Analysis
BTIG Reaffirms Their Buy Rating on Cue Health (HLTH)
Analysts Offer Insights on Healthcare Companies: Asensus Surgical (ASXC), Cue Health (HLTH) and Heron Therapeutics (HRTX)
Goldman Sachs Maintains Neutral on Cue Health, Lowers Price Target to $0.5
Cue Health Analyst Ratings
Goldman Sachs Downgrades Cue Health to Neutral From Buy, Trims Price Target to $0.75 From $2.75
Goldman Sachs Downgrades Cue Health (HLTH) to a Hold
BTIG Cuts Cue Health's Price Target to $3 From $5, Maintains Buy Rating
BTIG Sticks to Their Buy Rating for Cue Health (HLTH)
Goldman Sachs Adjusts Price Target on Cue Health to $3 From $3.50, Maintains Buy Rating
Goldman Sachs Maintains Buy on Cue Health, Lowers Price Target to $3
BTIG Sticks to Their Buy Rating for Cue Health (HLTH)
Morgan Stanley Keeps Their Hold Rating on Cue Health (HLTH)
Cowen Trims Price Target on Cue Health to $7 From $9, Maintains Outperform Rating
Cue Health Analyst Ratings
BTIG Remains a Buy on Cue Health (HLTH)